Discontinuation report CLOXACILLIN SODIUM FOR INJECTION

Last updated on 2017-06-27 History
Report ID 14014
Drug Identification Number 01912429
Brand name CLOXACILLIN SODIUM FOR INJECTION
Common or Proper name CLOXACILLIN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) CLOXACILLIN SODIUM
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 500MG
ATC code J01CF
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-03-03
Remaining supply date 2017-03-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2017-06-27 French Compare
v2 2017-06-27 English Compare
v1 2017-06-27 English Compare